Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2005 1
2020 2
2021 9
2022 6
2023 8
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

26 results

Results by year

Filters applied: . Clear all
Page 1
Did you mean chandiramani singh[Author] (1 results)?
CAR T cell therapy: newer approaches to counter resistance and cost.
Yadav RK, Ali A, Kumar S, Sharma A, Baghchi B, Singh P, Das S, Singh C, Sharma S. Yadav RK, et al. Among authors: singh c. Heliyon. 2020 Apr 16;6(4):e03779. doi: 10.1016/j.heliyon.2020.e03779. eCollection 2020 Apr. Heliyon. 2020. PMID: 32322738 Free PMC article. Review.
Phase III Pivotal comparative clinical trial of intranasal (iNCOVACC) and intramuscular COVID 19 vaccine (Covaxin®).
Singh C, Verma S, Reddy P, Diamond MS, Curiel DT, Patel C, Jain MK, Redkar SV, Bhate AS, Gundappa V, Konatham R, Toppo L, Joshi AC, Kushwaha JS, Singh AP, Bawankule S, Ella R, Prasad S, Ganneru B, Chiteti SR, Kataram S, Vadrevu KM. Singh C, et al. NPJ Vaccines. 2023 Aug 18;8(1):125. doi: 10.1038/s41541-023-00717-8. NPJ Vaccines. 2023. PMID: 37596281 Free PMC article.
Immunogenicity and safety of Biological E's CORBEVAX™ vaccine compared to COVISHIELD™ (ChAdOx1 nCoV-19) vaccine studied in a phase-3, single blind, multicentre, randomized clinical trial.
Thuluva S, Paradkar V, Gunneri S, Yerroju V, Mogulla R, Suneetha PV, Turaga K, Kyasani M, Manoharan SK, Adabala S, Sri Javvadi A, Medigeshi G, Singh J, Shaman H, Binayke A, Zaheer A, Awasthi A, Singh C, Rao A V, Basu I, Kumar KAA, Pandey AK. Thuluva S, et al. Among authors: singh c. Hum Vaccin Immunother. 2023 Dec 31;19(1):2203632. doi: 10.1080/21645515.2023.2203632. Epub 2023 Apr 27. Hum Vaccin Immunother. 2023. PMID: 37113012 Free PMC article. Clinical Trial.
Persistence of immunity and impact of third dose of inactivated COVID-19 vaccine against emerging variants.
Vadrevu KM, Ganneru B, Reddy S, Jogdand H, Raju D, Sapkal G, Yadav P, Reddy P, Verma S, Singh C, Redkar SV, Gillurkar CS, Kushwaha JS, Mohapatra S, Bhate A, Rai SK, Ella R, Abraham P, Prasad S, Ella K. Vadrevu KM, et al. Among authors: singh c. Sci Rep. 2022 Jul 14;12(1):12038. doi: 10.1038/s41598-022-16097-3. Sci Rep. 2022. PMID: 35835822 Free PMC article. Clinical Trial.
Impact of IRS: Four-years of entomological surveillance of the Indian Visceral Leishmaniases elimination programme.
Deb R, Singh RP, Mishra PK, Hitchins L, Reid E, Barwa AM, Patra D, Das C, Sukla I, Srivastava AK, Raj S, Mishra S, Swain M, Mondal S, Mandal U, Foster GM, Trett A, Garrod G, McKenzie L, Ali A, Morchan K, Chaudhuri I, Roy N, Gill NK, Singh C, Agarwal N, Sharma S, Stanton MC, Hemingway J, Srikantiah S, Coleman M. Deb R, et al. Among authors: singh c. PLoS Negl Trop Dis. 2021 Aug 9;15(8):e0009101. doi: 10.1371/journal.pntd.0009101. eCollection 2021 Aug. PLoS Negl Trop Dis. 2021. PMID: 34370731 Free PMC article.
Development and Evaluation of Active Case Detection Methods to Support Visceral Leishmaniasis Elimination in India.
Dubey P, Das A, Priyamvada K, Bindroo J, Mahapatra T, Mishra PK, Kumar A, Franco AO, Rooj B, Sinha B, Pradhan S, Banerjee I, Kumar M, Bano N, Kumar C, Prasad C, Chakraborty P, Kumar R, Kumar N, Kumar A, Singh AK, Kundan K, Babu S, Shah H, Karthick M, Roy N, Gill NK, Dwivedi S, Chaudhuri I, Hightower AW, Chapman LAC, Singh C, Sharma MP, Dhingra N, Bern C, Srikantiah S. Dubey P, et al. Among authors: singh c. Front Cell Infect Microbiol. 2021 Mar 24;11:648903. doi: 10.3389/fcimb.2021.648903. eCollection 2021. Front Cell Infect Microbiol. 2021. PMID: 33842396 Free PMC article.
Safety and immunogenicity of an inactivated SARS-CoV-2 vaccine, BBV152: a double-blind, randomised, phase 1 trial.
Ella R, Vadrevu KM, Jogdand H, Prasad S, Reddy S, Sarangi V, Ganneru B, Sapkal G, Yadav P, Abraham P, Panda S, Gupta N, Reddy P, Verma S, Kumar Rai S, Singh C, Redkar SV, Gillurkar CS, Kushwaha JS, Mohapatra S, Rao V, Guleria R, Ella K, Bhargava B. Ella R, et al. Among authors: singh c. Lancet Infect Dis. 2021 May;21(5):637-646. doi: 10.1016/S1473-3099(20)30942-7. Epub 2021 Jan 21. Lancet Infect Dis. 2021. PMID: 33485468 Free PMC article. Clinical Trial.
Acute Necrotizing Encephalitis as a Probable Association of COVID-19.
Kumar N, Kumar S, Kumar A, Pati BK, Kumar A, Singh C, Sarfraz A. Kumar N, et al. Among authors: singh c. Indian J Crit Care Med. 2020 Oct;24(10):991-994. doi: 10.5005/jp-journals-10071-23636. Indian J Crit Care Med. 2020. PMID: 33281329 Free PMC article.
26 results